Jardiance (empagliflozin) 25 mg is a medication used to manage type 2 diabetes by belonging to a class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. The primary mechanism of action of Jardiance involves the kidneys and glucose regulation.